JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk
JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk
Recalling Firm: Communications and Public Affairs Branch
Reason for Recall / Hazard
Product safety
Product Description & Identification
Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0.0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada.
Affected Products
JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 75604 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/jamp-digoxin-tablets-one-lot-recalled-due-possible-oversized-tablets-which-may-pose |
| Issue | Product safety |
| Title | JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk |
| Product | JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025) |
| Archived | 0 |
| Category | Health products |
| Last updated | 2024-05-31 |
| Organization | Communications and Public Affairs Branch |
| What you should do | Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0.0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada. |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmCommunications and Public Affairs Branch
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Communications and Public Affairs Branch - JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk Check if your household is affected: https://therecallfile.com/recalls/jamp-digoxin-tablets-one-lot-recalled-due-to-possible-oversized-tablet/CANADA-75604
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.